Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and palliative care.

Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States Division of Infectious Disease and Vaccinology, ...

Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each patient revealed pulmonary embolism, the ...

Our lymphatic system is like a big network of roots spread throughout the body. It serves as part of our immune system, transporting immune cells and filtering excess fluid (lymph) before returning it ...

NEW ORLEANS -- More extensive N1 lymph node assessment may better guide therapy after non-small cell lung cancer (NSCLC) resections with curative intent, real-world data suggested. The more N1 ...

Pulmonary sarcoidosis is the most common and clinically relevant manifestation of this multisystem granulomatous disease, yet imaging tools that accurately reflect inflammatory activity remain limited ...

You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical ...

As I was getting up from my visit with Mrs. Gregory, her right hand went to the base of her neck. Dr. Smith, do you think this little lump is anything?” Though doing her best to portray calm, she ...

Setting Two tertiary hospitals in south-central China. Patient data were consecutively enrolled from 1 June 2020 to 30 June 2023. Participants Of 2486 patients with pathologically confirmed thoracic ...

This fact sheet explains how lung cancer is staged, and what each stage means. Lung cancer staging can be complex, but this fact sheet is intended for patient education. Our easy-to-read fact sheets ...

The prognosis of patients with lung cancer and interstitial lung disease (ILD) is worse than that of patients without ILDs; however, therapeutic options for ILD-associated lung cancer are severely ...